Learn how smiling — and mimicking other people’s smiles — can make you seem more trustworthy and confident.

DESTINY-Endometrial02 is a phase 3 trial assessing T-DXd as an adjuvant treatment for HER2-expressing endometrial cancer, ...

At the British School of Bucharest (BSB), learning extends beyond desks, textbooks and examinations into a broader ...

Explore the role of patient-derived biology in enhancing antibody-drug conjugates for more effective cancer treatment.

Daiichi Sankyo &AstraZeneca’s Enhertu approved in China as first HER2 directed medicine for patients with HER2 low or HER2 ultralow metastatic breast cancer ...

Invivyd, Inc. (Nasdaq: IVVD) today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation for VYD2311, an investigational vaccine-alternative monoclonal antibody ...

First Quarter Highlights (fiscal 2026 versus fiscal 2025) ...

Study did not demonstrate statistically significant improvement on primary endpoint of reduction in anxiety as measured by SUDS scores compared to placeboFavorable safety and tolerability data were ...

Last week, Sen. Charles Schumer, the leader of the Democrats in the United States Senate, introduced a resolution on behalf of himself and 40 other Senate Democrats that, if passed, would record the ...

By combining material-level authentication, biometric human identity, and operational supply-chain controls, the initiative aims to demonstrate how next-generation physical-to-digital infrastructure ...

The engagement establishes a multi-phase framework to support AI enabled capital efficient development of Teverelix, a next generation GnRH antagonist, as a first in class market product for acute ...

The Phase 1 Program is tailored to advance the district-scale gold and silver potential of Lake Cargelligo during strong ...